AESGP Webinar: OTC products comm.s strategy in Europe: 5 hidden compliance risks you can’t ignore.

We'd like to invite you to join us on 17 September for an online webinar featuring Katleen Vandeweyer, External Senior Advisor Public Affairs and Market Access at Ogilvy Healthcare Brussels. 

The European pharmaceutical landscape is shifting faster than most OTC communication strategies can keep up with. This session cuts through the noise: what the EU Pharma Reform really means for self-care communication, where the risks lie, and how OTC companies need to adapt. 

What we’ll cover.

The EU Pharma Reform is the most significant overhaul of pharmaceutical law in 20 years, and its implications for OTC go well beyond product classification. This webinar focuses on what it means for how you communicate.

What we’ll run through.

• EU Pharma Reform: New rules. New risks. New opportunities. Discover how the EU Pharma Reform could reshape market access, Rx-to-OTC switches, portfolio strategy, and stakeholder communication.

• 5 hidden communication compliance risks you can't ignore: from cross-border compliance gaps and AI-generated content to consumer trust erosion.

• How to adapt: what responsible, effective OTC communication looks like in this environment, and why aligning Public Affairs, Regulatory and Communication is no longer optional.

Speaker.

Katleen Vandeweyer brings over 25 years of experience helping healthcare organizations navigate the intersection of go-to-market strategy, market access, public affairs, regulatory affairs, and strategic communication. A pharmacist and health economist by training, she holds an Executive Master's degree in EU Public Affairs & Communication and is an ICF Certified Coach.